Edition:
United States

Chemours Co (CC.N)

CC.N on New York Stock Exchange

44.88USD
13 Jul 2018
Change (% chg)

$0.12 (+0.27%)
Prev Close
$44.76
Open
$44.51
Day's High
$45.27
Day's Low
$44.51
Volume
277,790
Avg. Vol
393,231
52-wk High
$58.07
52-wk Low
$43.06

Latest Key Developments (Source: Significant Developments)

Chemours Announces Commencement Of Public Offering Of Senior Notes
Monday, 21 May 2018 07:12am EDT 

May 21 (Reuters) - Chemours Co ::CHEMOURS ANNOUNCES COMMENCEMENT OF PUBLIC OFFERING OF SENIOR NOTES.CHEMOURS - NET PROCEEDS OF OFFERING TO BE USED TO FUND PURCHASE PRICE, ACCRUED, UNPAID INTEREST FOR UP TO $250 MILLION OF 6.625% SENIOR NOTES DUE 2023.CHEMOURS - NET PROCEEDS OF OFFERING ALSO TO BE USED TO FUND PURCHASE PRICE, ACCRUED, UNPAID INTEREST FOR ANY, ALL OF CO'S 6.125% SENIOR NOTES DUE 2023.  Full Article

Chemours Sees FY 2018 ADJ EPS At High End Of Previous Guidance Of $4.95 To $5.60
Monday, 26 Mar 2018 04:52pm EDT 

March 26 (Reuters) - Chemours Co ::THE CHEMOURS COMPANY UPDATES 2018 OUTLOOK AND ANNOUNCES DATES FOR FIRST QUARTER 2018 EARNINGS RELEASE AND WEBCAST CONFERENCE CALL.CHEMOURS SEES FY 2018 ADJUSTED EARNINGS PER SHARE AT HIGH END OF PREVIOUS GUIDANCE OF $4.95 TO $5.60.CHEMOURS CO - SEES 2018 ADJUSTED EBITDA AT HIGH END OF PREVIOUSLY COMMUNICATED $1.7 BILLION TO $1.85 BILLION RANGE.CHEMOURS CO - ‍NOW EXPECTS EARNINGS TO BE IN TOP END OF ITS PREVIOUSLY ANNOUNCED RANGE​.CHEMOURS CO - ‍CURRENTLY EVALUATING IMPACT OF MORE FAVORABLE CONDITIONS TO LONGER-TERM TARGETS​.  Full Article

Chemours Updates 2017 Forecast, Provides 2018 Outlook, 2020 Key Financial Targets
Friday, 1 Dec 2017 11:25am EST 

Dec 1 (Reuters) - Chemours Co ::THE CHEMOURS COMPANY HOSTS FIRST INVESTOR DAY.CHEMOURS CO - BOARD OF DIRECTORS AUTHORIZED A $500 MILLION SHARE REPURCHASE PLAN.CHEMOURS CO - 2018 ‍ ADJUSTED EBITDA EXPECTED TO BE BETWEEN $1.7 AND $1.85 BILLION​.CHEMOURS CO - UNVEIL NEW CAPITAL ALLOCATION STRATEGY, WHICH IS EXPECTED TO RETURN NEARLY $900 MILLION TO SHAREHOLDERS OVER NEXT THREE YEARS.CHEMOURS CO - EXPECT TO INCREASE 2018 FREE CASH FLOW TO BE WITHIN RANGE OF $500 TO $600 MILLION, EVEN AFTER INVESTING IN TWO NEW MANUFACTURING FACILITIES.CHEMOURS - BOARD APPROVED Q1 CASH DIVIDEND OF $0.17 PER SHARE, AN INCREASE OF $0.14 PER SHARE FROM PREVIOUS LEVEL.CHEMOURS CO - EXPECTED TO GENERATE CUMULATIVE FREE CASH FLOW WITHIN A RANGE OF $2.0 BILLION AND $2.75 BILLION THROUGH 2020.CHEMOURS CO - $500 MILLION SHARE REPURCHASE PLAN EXTENDS THROUGH END OF 2020.CHEMOURS CO - SEES FULL-YEAR 2017 ADJUSTED EBITDA OF APPROXIMATELY $1.4 BILLION.CHEMOURS CO - EXPECT TO GROW ADJUSTED EPS BY 15 PERCENT OR GREATER THROUGH 2020 ON A COMPOUNDED ANNUAL BASIS OVER 2017.CHEMOURS - DEMAND FOR TI-PURE TITANIUM DIOXIDE, OPTEON REFRIGERANTS, FLUOROPOLYMERS AND CHEMICAL SOLUTIONS PRODUCTS CONTINUE TO DRIVE CO'S RESULTS.CHEMOURS CO - EXPECT TO CONTINUE TO GENERATE A RETURN ON INVESTED CAPITAL IN EXCESS OF 30 PERCENT & CO POISED FOR GROWTH THROUGH 2020 AND BEYOND.  Full Article

The Chemours Company reports third quarter results
Thursday, 2 Nov 2017 04:15pm EDT 

Nov 2 (Reuters) - Chemours Co :The Chemours Company reports third quarter results.Q3 earnings per share $1.08.Q3 sales $1.6 billion versus I/B/E/S view $1.59 billion.Q3 earnings per share view $1.04 -- Thomson Reuters I/B/E/S.Q3 adjusted earnings per share $1.12.Chemours Co - ‍full-year outlook reaffirmed​.FY2017 earnings per share view $3.57, revenue view $6.13 billion -- Thomson Reuters I/B/E/S.  Full Article

UTR partners with Chemours to develop anode material
Wednesday, 25 Oct 2017 09:07pm EDT 

Oct 26 (Reuters) - Ultracharge Ltd :Co ‍entered into agreement with Chemours to jointly develop anode material.  Full Article

Chemours qtrly adjusted net income was $0.08 per share
Wednesday, 15 Feb 2017 04:44pm EST 

Chemours Co : Chemours says quarterly adjusted net income of $15 million, or $0.08 per diluted share . Chemours says quarterly net sales of $1.3 billion . Q4 earnings per share view $0.29, revenue view $1.24 billion -- Thomson Reuters I/B/E/S . Quarterly sales decline driven by lower seasonal volumes in titanium technologies, a decline in base refrigerant volumes, and effects of divestitures . Expects to generate greater than $1 billion in adjusted EBITDA in 2017 .Completed strategic review of Chemical Solutions portfolio, delivered $200 million in cost savings this year, sees additional $150 million in cost savings.  Full Article

KBR awarded Corpus Christi Construction Contract from Chemours
Monday, 8 Aug 2016 06:00am EDT 

KBR INC : KBR awarded Corpus Christi Construction Contract from Chemours .Revenue associated with project will be booked into backlog of unfilled orders for KBR'S E&C business segment in Q3 of 2016.  Full Article

BRIEF-Chemours Announces Pricing Of Public Offering Of €450 Million Of 4.000% Senior Notes Due 2026

* CHEMOURS ANNOUNCES PRICING OF PUBLIC OFFERING OF €450 MILLION OF 4.000% SENIOR NOTES DUE 2026